JP2011510984A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510984A5
JP2011510984A5 JP2010545030A JP2010545030A JP2011510984A5 JP 2011510984 A5 JP2011510984 A5 JP 2011510984A5 JP 2010545030 A JP2010545030 A JP 2010545030A JP 2010545030 A JP2010545030 A JP 2010545030A JP 2011510984 A5 JP2011510984 A5 JP 2011510984A5
Authority
JP
Japan
Prior art keywords
progesterone
elastomer
polysiloxane
ring
intravaginal ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010545030A
Other languages
English (en)
Japanese (ja)
Other versions
JP5507467B2 (ja
JP2011510984A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/000672 external-priority patent/WO2009099586A2/en
Publication of JP2011510984A publication Critical patent/JP2011510984A/ja
Publication of JP2011510984A5 publication Critical patent/JP2011510984A5/ja
Application granted granted Critical
Publication of JP5507467B2 publication Critical patent/JP5507467B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010545030A 2008-02-04 2009-02-03 プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用 Active JP5507467B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2611508P 2008-02-04 2008-02-04
US61/026,115 2008-02-04
US13945408P 2008-12-19 2008-12-19
US61/139,454 2008-12-19
PCT/US2009/000672 WO2009099586A2 (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014055994A Division JP6124411B2 (ja) 2008-02-04 2014-03-19 プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用

Publications (3)

Publication Number Publication Date
JP2011510984A JP2011510984A (ja) 2011-04-07
JP2011510984A5 true JP2011510984A5 (enExample) 2012-03-22
JP5507467B2 JP5507467B2 (ja) 2014-05-28

Family

ID=40939073

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010545030A Active JP5507467B2 (ja) 2008-02-04 2009-02-03 プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用
JP2014055994A Active JP6124411B2 (ja) 2008-02-04 2014-03-19 プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014055994A Active JP6124411B2 (ja) 2008-02-04 2014-03-19 プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用

Country Status (26)

Country Link
US (5) US8580293B2 (enExample)
EP (2) EP2359807B1 (enExample)
JP (2) JP5507467B2 (enExample)
KR (3) KR20100133969A (enExample)
CN (2) CN104146948B (enExample)
AR (1) AR070561A1 (enExample)
AU (1) AU2009210779B2 (enExample)
BR (1) BRPI0905946B8 (enExample)
CA (2) CA2713943C (enExample)
CL (1) CL2009000242A1 (enExample)
DK (2) DK2359807T3 (enExample)
EA (2) EA021615B1 (enExample)
ES (2) ES2645630T3 (enExample)
HR (1) HRP20171319T1 (enExample)
HU (1) HUE035634T2 (enExample)
IL (2) IL207376A (enExample)
LT (1) LT2249757T (enExample)
MX (2) MX385981B (enExample)
NZ (3) NZ596844A (enExample)
PL (2) PL2249757T3 (enExample)
PT (2) PT2359807T (enExample)
SG (2) SG10201605171QA (enExample)
SI (2) SI2359807T1 (enExample)
TW (3) TWI599359B (enExample)
WO (1) WO2009099586A2 (enExample)
ZA (2) ZA201307321B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai
JP2013535992A (ja) * 2010-06-22 2013-09-19 テバ ウィメンズ ヘルス インコーポレイテッド 抗コリン作動剤を含む膣内用デバイスおよびそれを作る方法
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2641602A1 (en) * 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
WO2014122563A1 (en) * 2013-02-08 2014-08-14 Qpharma Ab An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device
CN103394127A (zh) * 2013-08-02 2013-11-20 苏州市马尔泰新材料有限公司 一种含有中西医药的阴道模具材料
CN103431930A (zh) * 2013-08-02 2013-12-11 苏州市马尔泰新材料有限公司 一种含有甲酯树脂的阴道模具
CN103394128A (zh) * 2013-08-02 2013-11-20 苏州市马尔泰新材料有限公司 一种含有川芎的模具材料
CN103405810A (zh) * 2013-08-02 2013-11-27 苏州市马尔泰新材料有限公司 一种含有甲基丙烯酸甲酯树脂的阴道模具
CN103445892A (zh) * 2013-08-02 2013-12-18 苏州市马尔泰新材料有限公司 一种含有甲酯树脂和雌酚的阴道模具
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN112494195A (zh) 2014-04-01 2021-03-16 保利医学公司 避孕装置及相关装置
ES2699003T3 (es) * 2014-06-28 2019-02-06 Laboratorios Andromaco S A Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, usado para la prevención de partos prematuros
CN104546267B (zh) * 2015-01-13 2017-01-04 安徽农业大学 一种犬用宫外节育装置及其节育方法
BR112018012744A2 (pt) * 2015-12-21 2018-12-04 Bayer Oy método de fabricação de um anel vaginal
EP3542786A1 (en) * 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices
CN114126710A (zh) * 2019-03-29 2022-03-01 B·马特尔 含有孕酮的eva分段式阴道内环
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11439588B2 (en) * 2019-10-12 2022-09-13 National Research Institute For Family Planning Vaginal sustained-release drug delivery system for luteal support, method for preparation and use thereof
TWI791347B (zh) * 2020-12-11 2023-02-01 酷氏基因生物科技股份有限公司 一種用於評估胚胎植入成功率的預測方法

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE494972A (enExample) 1949-04-07
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (enExample) 1953-11-19
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
FR2618329B1 (fr) 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US5116619A (en) * 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
DE3838815A1 (de) * 1988-11-17 1990-05-23 Hoechst Ag Verfahren zum herstellen eines intravaginalen applikationssystems
US6264638B1 (en) * 1989-12-07 2001-07-24 Ultrafem, Inc. Intravaginal drug delivery system and discharge collection device
US5340585A (en) * 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
IT1256393B (it) 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
EP0836473B1 (en) * 1995-07-04 2001-10-31 Akzo Nobel N.V. Ring-shaped devices
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5744463A (en) * 1996-06-03 1998-04-28 Bair; Glenn O. Treatment of side effects of progestins and progesterone analogues used for birth control
US5869081A (en) * 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US5985861A (en) * 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
NZ501236A (en) * 1997-05-07 2002-02-01 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6039968A (en) 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6245757B1 (en) * 1997-10-03 2001-06-12 Research Corporation Technologies, Inc. Use of progestins to treat ischemic event
US6306914B1 (en) * 1997-10-21 2001-10-23 Columbia Laboratories, Inc. Progestin therapy for maintaining amenorrhea
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
AU748653B2 (en) * 1998-05-01 2002-06-06 John F. Cline Method for injection molding manufacture of controlled release devices
JP2002518351A (ja) 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US7001609B1 (en) * 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6063395A (en) 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US20050197651A1 (en) * 2001-04-25 2005-09-08 Chen Hai L. Vaginal ring preparation and its application
CN1210079C (zh) * 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
AU2003208679A1 (en) * 2002-02-08 2003-09-02 Advanced Animal Technology Limited Control of a biological function
EP1494646B2 (en) * 2002-03-27 2017-10-04 Warner Chilcott (Ireland) Limited Intravaginal matrix drug delivery devices
CA2504283A1 (en) * 2002-10-31 2004-05-21 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia
US20040089308A1 (en) * 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
FR2849380A1 (fr) * 2002-12-27 2004-07-02 Ernest Loumaye NOUVELLE UTILISATION D'UN AGONISTE DU GnRH
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
CA2531640C (en) * 2003-07-10 2013-06-18 Galen (Chemicals) Limited Intravaginal drug delivery devices
US20050255157A1 (en) * 2004-05-11 2005-11-17 Glenmark Pharmaceuticals Limited Sustained release, mucoadhesive vaginal pharmaceutical compositions
US7707169B2 (en) 2004-06-10 2010-04-27 Siemens Corporation Specification-based automation methods for medical content extraction, data aggregation and enrichment
KR101229701B1 (ko) * 2004-07-09 2013-02-05 라보라토이레 에이치알에이 파르마 프로게스테론 수용체 조절제를 함유하는 서방형 조성물
AR043476A1 (es) * 2004-09-09 2005-08-03 Dvoskin Victor Oscar Dispositivo de administracion regulada de sustancias para la insercion en una cavidad corporal y procedimiento para fabricar un medio de soporte de dichas sustancias
US7517914B2 (en) * 2005-04-04 2009-04-14 Boston Scientificscimed, Inc. Controlled degradation materials for therapeutic agent delivery
US8399012B2 (en) * 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
JP2009536164A (ja) * 2006-05-10 2009-10-08 エボニック デグサ ゲーエムベーハー ロール圧密成形した熱分解法二酸化ケイ素の医薬組成物での使用
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
US20080214512A1 (en) * 2007-03-01 2008-09-04 Christian Seitz Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation
CA2823407C (en) * 2007-03-22 2016-10-18 Berg Pharma Llc Topical formulations having enhanced bioavailability
WO2008140794A1 (en) 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai

Similar Documents

Publication Publication Date Title
JP2011510984A5 (enExample)
HRP20171319T1 (hr) Monolitni intravaginalni prsten koji sadrži progesteron i metode njegove izrade i uporabe
CN1270718C (zh) 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用
JP2006104221A5 (enExample)
JP2008535850A5 (enExample)
HRP20131073T1 (hr) Organski spojevi
JPH01221318A (ja) ダナゾール含有の局所投与製剤
JP2013529665A5 (enExample)
CN1522147B (zh) 含有15-酮基-前列腺素类化合物的用于治疗药物诱导的便秘的组合物
JP2016510041A5 (enExample)
TW200521117A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO1999017737A1 (fr) Composition de suppositoire
Samborski et al. Intra‐articular treatment of arthritides and activated osteoarthritis with the 5‐HT3 receptor antagonist tropisetron. A double‐blind study compared with methylprednisolone
JP2011195430A (ja) 低収縮性セメント組成物
CN110141653B (zh) 一种含总姜酚的组合物及其制备方法
CN102872026A (zh) 一种化合物的新用途
JP2008001688A (ja) 痔疾治療用組成物
KR20200135443A (ko) 프로게스테론 질내 장치
RU2018134045A (ru) Пролекарства селективного модулятора рецептора прогестерона (sprm) (11.бета.,17.бета.)-17-гидрокси-11-[4-(метилсульфонил)фенил]-17-(пентафторэтил))эстра-4,9-диен-3-она
RU2009115643A (ru) Модуляторы прогестеронового рецептора на основе пиридооксазепина
US20130172306A1 (en) Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases
JP2014024768A (ja) 皮膚外用剤組成物
Park et al. Changes in awake cystometry and expression of bladder β-adrenoceptors after partial bladder outlet obstruction in male rats
JP2007008871A (ja) 経皮吸収促進組成物
CN101007091B (zh) 一种治疗妇女原发性痛经的中药复方制剂